121 related articles for article (PubMed ID: 809441)
21. Preparation and characterization of antibody to galactosyl(alpha 1 leads to 4)galactosyl(beta 1 leads to 4)glucosylceramide.
Clarke JT; Embil JA
Biochim Biophys Acta; 1979 Jan; 582(2):283-94. PubMed ID: 760826
[TBL] [Abstract][Full Text] [Related]
22. Fabry's disease--a case report and review of literatures reported in Korea.
Lee SY; Kim SJ; Lee JI; Kim ES; Lee CH; Kim JH; Jeong HJ; Ha SK
Yonsei Med J; 1998 Feb; 39(1):67-72. PubMed ID: 9529988
[TBL] [Abstract][Full Text] [Related]
23. Fabry's disease as a differential diagnosis of MS.
Callegaro D; Kaimen-Maciel DR
Int MS J; 2006 Jan; 13(1):27-30. PubMed ID: 16420782
[TBL] [Abstract][Full Text] [Related]
24. Influence of monovalent cation transport on anabolism of glycosphingolipids in cultured human fibroblasts.
Saito M; Saito M; Rosenberg A
Biochemistry; 1985 Jun; 24(12):3054-9. PubMed ID: 4016085
[TBL] [Abstract][Full Text] [Related]
25. Decline of plasma brain natriuretic peptide during enzyme replacement therapy in a female patient with heterozygous Fabry's disease.
Masugata H; Senda S; Goda F; Yamagami A; Okuyama H; Kohno T; Hosomi N; Yukiiri K; Noma T; Murao K; Kohno M; Itoh S
Tohoku J Exp Med; 2009 Mar; 217(3):169-74. PubMed ID: 19282651
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabry disease by tandem mass spectrometry.
Mills K; Johnson A; Winchester B
FEBS Lett; 2002 Mar; 515(1-3):171-6. PubMed ID: 11943216
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the photooxidation of galactosyl- and lactosylceramide by electrospray ionization mass spectrometry.
Santinha D; Ferreira-Fernandes E; Melo T; Silva EM; Maciel E; Fardilha M; Domingues P; Domingues MR
Rapid Commun Mass Spectrom; 2014 Nov; 28(21):2275-84. PubMed ID: 25279740
[TBL] [Abstract][Full Text] [Related]
28. Glycosphingolipid depletion in fabry disease lymphoblasts with potent inhibitors of glucosylceramide synthase.
Abe A; Arend LJ; Lee L; Lingwood C; Brady RO; Shayman JA
Kidney Int; 2000 Feb; 57(2):446-54. PubMed ID: 10652021
[TBL] [Abstract][Full Text] [Related]
29. Trihexosylceramide alpha-galactosidase of human leucocytes.
Poulos A; Beckman K
Clin Chim Acta; 1978 Oct; 89(1):35-45. PubMed ID: 101320
[TBL] [Abstract][Full Text] [Related]
30. Isolation and structural characterization of glycosphingolipids of in vitro propagated bovine aortic endothelial cells.
Duvar S; Peter-Katalinić J; Hanisch FG; Müthing J
Glycobiology; 1997 Dec; 7(8):1099-109. PubMed ID: 9455911
[TBL] [Abstract][Full Text] [Related]
31. Plasma exchange removes glycosphingolipid in Fabry disease.
Pyeritz RE; Ullman MD; Moser AB; Braine HG; Moser HW
Am J Med Genet; 1980; 7(3):301-7. PubMed ID: 6781344
[TBL] [Abstract][Full Text] [Related]
32. Excellent outcome of renal transplantation in patients with Fabry's disease.
Ojo A; Meier-Kriesche HU; Friedman G; Hanson J; Cibrik D; Leichtman A; Kaplan B
Transplantation; 2000 Jun; 69(11):2337-9. PubMed ID: 10868636
[TBL] [Abstract][Full Text] [Related]
33. Avascular necrosis of the femoral head in a patient with Fabry's disease: identification of ceramide trihexoside in the bone by delayed-extraction matrix-assisted laser desorption ionization-time-of-flight mass spectrometry.
Horiuchi H; Saito N; Kobayashi S; Ota H; Taketomi T; Takaoka K
Arthritis Rheum; 2002 Jul; 46(7):1922-5. PubMed ID: 12124877
[TBL] [Abstract][Full Text] [Related]
34. [Angiokeratoma corporis diffusum (Fabry's disease). Biochemical diagnosis in plasma].
Atzpodien W; Kremer GJ; Schnellbacher E; Denk R; Haferkamp G; Bierbach H
Dtsch Med Wochenschr; 1975 Feb; 100(9):423-6. PubMed ID: 803896
[TBL] [Abstract][Full Text] [Related]
35. Use of [6,6-2H2]glucose and of low-enrichment [U-13C6]-glucose for sequential or simultaneous measurements of glucose turnover by gas chromatography-mass spectrometry.
Previs SF; Ciraolo ST; Fernandez CA; Beylot M; Agarwal KC; Soloviev MV; Brunengraber H
Anal Biochem; 1994 Apr; 218(1):192-6. PubMed ID: 8053553
[TBL] [Abstract][Full Text] [Related]
36. Urinary neutral glycosphingolipid analysis of patients with Fabry's disease; rapid isocratic elution from high-performance liquid chromatography as per-o-benzoyl derivatives.
Oshima M; Asano K; Shibata S; Suzuki Y; Masuzawa M
Biochim Biophys Acta; 1990 Apr; 1043(2):157-60. PubMed ID: 2107877
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of glycosphingolipids in spinal and sympathetic ganglia of a symptomatic heterozygote of Fabry's disease.
Hozumi I; Nishizawa M; Ariga T; Inoue Y; Ohnishi Y; Yokoyama A; Shibata A; Miyatake T
J Neurol Sci; 1989 May; 90(3):273-80. PubMed ID: 2500499
[TBL] [Abstract][Full Text] [Related]
38. D-galactosyl-beta1-1'-sphingosine and D-glucosyl-beta1-1'-sphingosine induce human natural killer cell apoptosis.
Maghazachi AA; Knudsen E; Jin Y; Jenstad M; Chaudhry FA
Biochem Biophys Res Commun; 2004 Jul; 320(3):810-5. PubMed ID: 15240120
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical localization of glycosphingolipid in urinary renal tubular cells in Fabry's disease.
Chatterjee S; Gupta P; Pyeritz RE; Kwiterovich PO
Am J Clin Pathol; 1984 Jul; 82(1):24-8. PubMed ID: 6430064
[TBL] [Abstract][Full Text] [Related]
40. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
Setnikar I; Rovati LC
Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
